top of page

Amantadine

Grade

Analgesia

Pharmacology
Therapeutics

Evidence

  1. Aiyer, R., Mehta, N., Gungor, S., Gulati, A., 2018. A Systematic Review of NMDA Receptor Antagonists for Treatment of Neuropathic Pain in Clinical Practice. Clin J Pain 34, 450–467. https://doi.org/10.1097/AJP.0000000000000547

  2. Collins, S., Sigtermans, M.J., Dahan, A., Zuurmond, W.W.A., Perez, R.S.G.M., 2010. NMDA receptor antagonists for the treatment of neuropathic pain. Pain Med 11, 1726–1742. https://doi.org/10.1111/j.1526-4637.2010.00981.x

  3. Fukui, S., Komoda, Y., Nosaka, S., 2001. Clinical application of amantadine, an NMDA antagonist, for neuropathic pain. J Anesth 15, 179–181. https://doi.org/10.1007/s005400170025

  4. Moore, S.A., 2016. Managing Neuropathic Pain in Dogs. Front Vet Sci 3, 12. https://doi.org/10.3389/fvets.2016.00012

  5. Sang, C.N., 2000. NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials. J Pain Symptom Manage 19, S21-25. https://doi.org/10.1016/s0885-3924(99)00125-6

  6. Weber, C., 1998. [NMDA-receptor antagonist in pain therapy]. Anasthesiol Intensivmed Notfallmed Schmerzther 33, 475–483. https://doi.org/10.1055/s-2007-994794


Monograph Details

bottom of page